Recombinant UPF0178 protein YaiI (YaiI) is a hypothetical protein encoded by the yaiI gene, classified under the UPF0178 family. It is expressed in bacterial species such as Escherichia coli O157:H7 and Salmonella typhimurium. This protein is of interest in structural and functional genomics due to its conserved but poorly characterized role in bacterial physiology .
Recombinant YaiI is produced using multiple expression platforms to meet research demands:
Hypothetical Role: Predicted to participate in stress response or metabolic regulation, though mechanistic insights remain limited .
Interaction Networks: Computational models suggest associations with membrane transporters or redox enzymes .
Antigen Production: Utilized for polyclonal antibody generation due to its immunogenicity .
Structural Biology: Serves as a target for X-ray crystallography or NMR to resolve 3D conformation .
UPF0178 protein yaiI is a full-length protein comprising 152 amino acids with a molecular weight of 16,969 Da. The complete amino acid sequence is: MTIWVDADACPNVIKEILYRAAE RMQMPLVLVANQSLRVPPSRFIRTLRVAAGFDVADNEIVRQCEAGDLVITADIPLAAE AIEKGAAALNPRGERYPTATIRERLTMRDFMDTLRASGIGTGGPDSLSQRDRQAFAAE LEKWWLEVQRSRG . The protein belongs to the UPF0178 family, with its structure suggesting potential roles in cellular processes that are still being elucidated through ongoing research.
Recombinant UPF0178 protein yaiI can be produced using multiple expression systems, each offering different advantages for research applications:
| Expression System | Product Code | Special Considerations |
|---|---|---|
| E. coli | CSB-EP359116EOD | Cost-effective, high yield for non-modified proteins |
| Yeast | CSB-YP359116EOD | Better for certain post-translational modifications |
| Baculovirus | CSB-BP359116EOD | Insect cell-based, complex eukaryotic modifications |
| Mammalian cell | CSB-MP359116EOD | Most authentic post-translational modifications |
Additionally, specialized variants such as Avi-tag Biotinylated versions (CSB-EP359116EOD-B) are available for applications requiring biotinylation .
Commercial preparations of recombinant UPF0178 protein yaiI typically achieve ≥85% purity as determined by SDS-PAGE analysis . This level of purity is generally sufficient for most biochemical and structural studies, though researchers requiring higher purity for specialized applications should consider additional purification steps following acquisition of the commercial product.
When designing proteomics experiments involving yaiI protein, computer modeling and simulation approaches can significantly improve experimental outcomes. Begin by clearly defining your research question, then model the experimental parameters before performing wet-lab work. As noted in proteomics research literature, "The complexity of proteomes makes good experimental design essential for their successful investigation" .
Recommended approach:
Define specific objectives (interaction partners, structural features, etc.)
Create a computer simulation of your experimental design
Identify potential confounding variables
Include appropriate controls (negative controls, positive controls with known interactors)
Consider statistical power requirements for meaningful results
Implement iterative refinement based on preliminary data
Based on protein characteristics and standard protocols for similar bacterial proteins, the following buffer conditions are recommended for maintaining yaiI stability:
| Buffer Component | Recommended Range | Rationale |
|---|---|---|
| pH | 7.0-8.0 | Optimal for maintaining native structure |
| Salt (NaCl) | 100-300 mM | Provides ionic strength without precipitation |
| Reducing agent | 1-5 mM DTT or TCEP | Prevents unwanted disulfide formation |
| Glycerol | 5-10% | Enhances stability for long-term storage |
| Protease inhibitors | As per manufacturer | Prevents degradation during experiments |
Storage should be at -80°C for long-term or -20°C with glycerol for medium-term stability. Working solutions should be kept on ice to minimize degradation.
Given that yaiI is a protein of unknown function (UPF), a multi-faceted approach is recommended:
Computational prediction: Utilize structural homology modeling to predict function based on similar protein domains.
Interactome analysis: Identify binding partners through techniques such as:
Affinity purification coupled with mass spectrometry
Yeast two-hybrid screening
Protein microarrays using recombinant yaiI as bait
Genetic approaches:
Gene knockout/knockdown studies in E. coli
Complementation assays
Phenotypic screening under various stress conditions
Biochemical characterization:
Enzymatic activity assays based on predicted function
Substrate screening if enzymatic activity is suspected
This combined approach follows the "design cycle" principles where "theory and experiment alternate" to progressively build understanding of protein function .
Proper folding is essential for functional studies. Several complementary methods should be employed:
Circular Dichroism (CD) Spectroscopy: Provides information about secondary structural elements (α-helices, β-sheets).
Thermal Shift Assays: Measures protein stability and can indicate proper folding through determination of melting temperature.
Limited Proteolysis: Well-folded proteins typically show resistance to proteolytic digestion except at exposed loops.
Size Exclusion Chromatography: Can indicate if the protein exists as a monomer or forms aggregates that may suggest improper folding.
Activity Assays: If function is known or predicted, functional assays provide the most relevant indication of proper folding.
Rational protein design for yaiI modification should follow the hierarchical approach described in the literature where "increasing levels of complexity are iteratively introduced" . This methodology involves:
Computational modeling: Create a molecular model based on the full sequence (MTIWVDADAC PNVIKEILYR AAERMQMPLV LVANQSLRVP PSRFIRTLRV AAGFDVADNE IVRQCEAGDL VITADIPLAA EAIEKGAAAL NPRGERYTPA TIRERLTMRD FMDTLRASGI QTGGPDSLSQ RDRQAFAAEL EKWWLEVQRS RG) .
Identify modification targets: Based on structural predictions, identify:
Surface residues for solubility enhancement
Core residues for stability modification
Active site residues (if known) for functional modification
Design mutants: Apply the "inverse folding" approach where you "keep [the backbone] fixed, and redecorate with different amino acid sequences that are predicted to be structurally compatible with that fold" .
Experimental validation: Produce and test modified variants, then:
Characterize structural changes
Assess functional impacts
Iterate design based on results
When faced with contradictory data regarding yaiI function, a systematic approach is necessary:
Data quality assessment:
Evaluate experimental reproducibility within and between labs
Assess reagent quality, particularly antibody specificity and protein purity
Review statistical analysis methods for potential biases
Experimental conditions comparison:
Create a comprehensive table of all experimental conditions (pH, temperature, buffer components, etc.)
Identify systematic differences that may explain divergent results
Theoretical framework evaluation:
Consider if contradictory results reflect different aspects of a multi-functional protein
Develop unifying hypotheses that accommodate seemingly contradictory data
Decisive experiments design:
Design experiments specifically to distinguish between competing hypotheses
Implement orthogonal techniques to validate findings
Consider in vivo relevance of in vitro findings
This approach reflects the scientific principle that contradictions often reveal new insights when properly investigated.
For identifying interaction partners of yaiI, a combination of complementary approaches yields the most reliable results:
Affinity-based methods:
Proximity-based methods:
Yeast two-hybrid screening
Bacterial two-hybrid systems (more relevant for bacterial proteins)
Proximity labeling approaches (BioID, APEX)
Biophysical interaction analysis:
Surface plasmon resonance (SPR)
Isothermal titration calorimetry (ITC)
Microscale thermophoresis (MST)
Computational prediction and validation:
Interactome database mining
Structural docking simulations
Functional association networks
Each method has distinct strengths and limitations, so concordance across multiple approaches provides the strongest evidence for genuine interactions.
Distinguishing specific from non-specific interactions requires rigorous experimental controls and validation:
Control proteins:
Use structurally similar but functionally distinct proteins as negative controls
Include known interaction partners as positive controls
Competition assays:
Perform binding in the presence of increasing concentrations of unlabeled protein
Specific interactions show competitive displacement; non-specific don't
Mutational analysis:
Systematically mutate surface residues of yaiI
Specific interactions are disrupted by mutations at the interaction interface
Concentration dependence:
Specific interactions typically show saturable binding kinetics
Non-specific interactions often increase linearly with concentration
Stringency conditions:
Increase salt concentration and detergent levels to disrupt non-specific interactions
Specific interactions typically withstand moderate increases in stringency
Common issues with yaiI expression and purification can be addressed through systematic troubleshooting:
| Issue | Potential Solutions |
|---|---|
| Low expression yield | - Optimize codon usage for expression host - Test different promoter systems - Adjust induction conditions (temperature, inducer concentration) - Consider fusion tags (MBP, SUMO) to enhance solubility |
| Protein insolubility | - Reduce expression temperature (16-20°C) - Add solubility enhancers to lysis buffer (0.1% Triton X-100, 10% glycerol) - Co-express with chaperones - Consider refolding from inclusion bodies |
| Proteolytic degradation | - Add protease inhibitor cocktail - Reduce purification time - Keep samples cold throughout purification - Consider C-terminal vs. N-terminal tags |
| Aggregation during storage | - Add stabilizing agents (glycerol, trehalose) - Optimize buffer conditions (pH, salt) - Store at appropriate concentration (avoid too concentrated) - Flash-freeze aliquots and avoid freeze-thaw cycles |
For particularly difficult cases, switching expression systems may be necessary. The baculovirus or mammalian expression systems offered by suppliers may provide better results for challenging proteins .
Reproducibility challenges in yaiI functional assays can be addressed through:
Standardization of reagents:
Use the same lot of recombinant protein when possible
Carefully document source, purity, and storage conditions
Create internal standards for normalization between experiments
Protocol documentation:
Develop detailed SOPs with explicit parameters
Record all environmental variables (temperature, humidity)
Use electronic lab notebooks for comprehensive documentation
Assay validation:
Determine assay precision through replicate measurements
Establish acceptance criteria before experiments
Include internal controls in every experiment
Statistical considerations:
Perform power analyses to determine appropriate sample sizes
Use appropriate statistical tests for data analysis
Consider blinding procedures for subjective measurements
Inter-laboratory validation:
Exchange protocols and samples with collaborating labs
Conduct parallel experiments to identify lab-specific variables
Develop robust assays that translate across different settings
This approach aligns with the principles of model-guided experimental design, where theory and experiment inform each other iteratively .
Emerging technologies that could significantly advance yaiI research include:
AlphaFold2 and structural prediction:
Leverage AI-based structural prediction to generate high-confidence structural models
Use predicted structures to inform functional hypotheses and guide experimental design
Cryo-EM and advanced structural biology:
Determine high-resolution structures of yaiI alone and in complexes
Visualize dynamic conformational changes under different conditions
Single-molecule techniques:
Employ FRET and other single-molecule approaches to study dynamics
Investigate individual molecular events rather than ensemble averages
Genome-wide screening approaches:
CRISPR-based functional genomics to identify genetic interactions
High-throughput phenotypic screening under diverse conditions
Systems biology integration:
Multi-omics data integration to place yaiI in broader cellular context
Network analysis to predict functional relationships
These approaches represent the frontier of protein characterization, moving beyond traditional reductionist approaches to more holistic understanding.
Computational approaches can significantly enhance experimental design for yaiI research through:
Molecular dynamics simulations:
Model protein behavior in different environments
Predict conformational changes and potential binding sites
Guide mutagenesis experiments by identifying critical residues
Machine learning for experimental optimization:
Develop predictive models for expression and purification conditions
Optimize buffer compositions for stability and activity
Design efficient experimental sampling strategies
Network-based functional prediction:
Identify potential functional associations through guilt-by-association methods
Predict cellular pathways involving yaiI
Prioritize hypotheses for experimental testing
In silico screening:
Virtual screening for potential ligands or inhibitors
Molecular docking to predict binding modes
Filter compounds for experimental validation
This integrated computational-experimental approach embodies the "design cycle" principle where "theory and experiment alternate" to efficiently build understanding , thereby reducing the immense combinatorial complexity inherent in protein research.